Insider Transactions Reported by 16 Insiders of ORAMED PHARMACEUTICALS INC.

Symbol
ORMP on Nasdaq
Location
New York, NY

There are no Buy or Sell transactions made by insiders since 08 Mar 2025

ORAMED PHARMACEUTICALS INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Nadav Kidron President and CEO, Director $9,562,428 22 Jan 2026
Benjamin Shapiro Director $6,150,588 31 Dec 2025
Miriam Kidron Chief Scientific Officer, Director $4,128,692 22 Jan 2026
Joshua Hexter Coo & Cbo $3,033,810 22 Jan 2026
Avraham Gabay Chief Financial Officer $1,850,379 22 Jan 2026
David Silberman Chief Financial Officer $809,965 04 Jan 2024
Arie Mayer Director $510,747 31 Dec 2025
Daniel Aghion Director $344,860 31 Dec 2025
Yadin Rozov Director $343,257 04 Jan 2024
Netanel Derovan Chief Legal Officer $330,395 26 May 2023
Yehuda Reznick Director $319,747 31 Dec 2025
Leonard Sank Director $301,349 05 Jun 2025
Michael Rabinowitz Chief Commercial Officer $278,776 03 Jan 2023
Michael Rabinowitz Chief Commercial Officer $241,924 03 Jan 2022
Kevin Rakin Director $103,121 21 Mar 2022
Aviad Friedman Director 03 Jan 2022

Recent Insider Transactions by Companies or Individuals for ORAMED PHARMACEUTICALS INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.